Clinical Trial Update: Enteral Glutamine in Neurologically-injured Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating enteral glutamine in neurologically injured patients, including traumatic brain injury, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Enteral Glutamine (glutamine)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Neurologic Injury, Traumatic Brain Injury | Phase 4 | Status: COMPLETED